MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2017 International Congress

    Disease severity is not predictive of the dose required for apomorphine sublingual film (APL-130277) to convert a patient with Parkinson’s disease(PD) from OFF to fully ON: Preliminary Results from a Phase III Study

    H. Fernandez, S. Isaacson, A. Espay, R. Pahwa, D. Truong, E. Pappert, P. Gardzinski, B. Dzyngel, A. Agro, R. Hauser (Cleveland, OH, USA)

    Objective: To determine if baseline disease severity could be correlated to the effective dose of APL-130277 that was required to turn a patient with PD…
  • 2017 International Congress

    Alternations of Metabolic Profile and Kynurenine Metabolism in the Plasma of Parkinson’s Disease

    C.-M. Chen, K.-H. Chang, Y.-R. Wu, M.-L. Cheng (Taoyuan, Taiwan)

    Objective: The purpose of this study was to identify potential plasma metabolic biomarkers for Parkinson’s disease (PD) Background: PD, characterized by a slowness of movement…
  • 2017 International Congress

    Study Design for a Multi-Modal Approach to Understanding Parkinson’s Disease: The Personalized Parkinson Project

    W. Marks, Jr., L. Evers, M. Faber, M. Verbeek, N. de Vries, B. Bloem (South San Francisco, CA, USA)

    Objective: We aim to create a longitudinal dataset of clinical, molecular, imaging, and continuous wearable sensor-based data from a representative Parkinson’s disease (PD) cohort. Data…
  • 2017 International Congress

    Quantitative demonstration of the efficacy of rotigotine transdermal patch in the treatment of nocturnal hypokinesia: A randomized, placebo-controlled trial using an axial inertial sensor

    R. Bhidayasiri, J. Sringean, S. Chaiwong, C. Anan, K. Boonpang, K. Sakdisornchai, O. Jitkritsadakul, P. Jagota (Bangkok, Thailand)

    Objective: To evaluate the efficacy of rotigotine transdermal patch, using a wearable sensor, to treat PD patients with nocturnal immobility. Background: Nocturnal hypokinesia is a…
  • 2017 International Congress

    Dopamine transporter imaging predicts motor response to dopaminergic therapy for patients with advanced Parkinson’s disease: Possible role in patient selection for subthalamic deep brain stimulation.

    A. Nakajima, Y. Shimo, S. Sekimoto, K. Kamagata, J. Takayuki, G. Oyama, A. Umemura, N. Hattori (Tokyo, Japan)

    Objective: To investigate the possible role of dopamine transporter (DAT) imaging in patient selection for subthalamic deep brain stimulation (STN-DBS) surgery, we retrospectively investigated the…
  • 2017 International Congress

    Clinical characteristics of scan without evidence of dopaminergic deficits (SWEDDs) in Japan.

    M. Takahashi, Y. Tashiro, N. Ito, T. Sato, T. Sekiguchi, A. Inaba, S. Orimo (Tokyo, Japan)

    Objective: To examine the clinical characteristics of SWEDDs and to compare to that of Parkinson’s disease (PD). Background: Patients with SWEDDs are defined as clinically…
  • 2017 International Congress

    Impacts of White Matter Hyperintensities on Limit of Stability in Drug-naïve, de novo Patients with Idiopathic Parkinson’s Disease

    J.-H. Park, S.-K. Lee, T.-K. Lee (Bucheon-si, Republic of Korea)

    Objective: The aims of this study were to investigate the effects of incidental white matter hyperintensities(WMH) on self-initiated postural control in drug-naïve, newly diagnosed Parkinson disease…
  • 2017 International Congress

    Spanish Primary Familial Brain Calcification caused by SLC20A2 mutation

    N. Caballol, E. Peral, M. Balague, E. Moral, L. Vila, G. Celma, L. Vives, I. Royo, A. Ferran, A. Torrents, E. Gean, A. Ávila (Sant Joan Despí, Spain)

    Objective: To describe clinical and radiological features of a Spanish family with Primary Familial Brain Calcification (PFBC) and genetic results of the index case. Background:…
  • 2017 International Congress

    General Anesthesia and Parkinson’s Disease

    C.-W. CHEN, K.-B. CHEN, Y.-C. KUO (TAICHUNG, Taiwan)

    Objective: Postoperative cognitive dysfunction is common among the elderly. These changes may even be so severe that some elderly people actually become demented after undergoing…
  • 2017 International Congress

    The impact of Parkinson’s disease on faith and spirituality

    A. Weldehana (Addis Ababa, Ethiopia)

    Objective: The objective of the present study is to assess the impact of Parkinson’s disease on faith and spirituality.  Background: There are some controversies on…
  • « Previous Page
  • 1
  • …
  • 314
  • 315
  • 316
  • 317
  • 318
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley